若您需要咨询产品或有任何技术问题,请通过官方电话 400 885 9050 或邮箱 info.cn@stemcell.com 与我们联系

EasySep™ HLA嵌合全血CD3正选试剂盒

从全血和白膜层中免疫磁珠正选人CD3+细胞

产品号 #(选择产品)

产品号 #17871_C

从全血和白膜层中免疫磁珠正选人CD3+细胞

产品优势

  • 快速、易于操作
  • 分选纯度高达99%
  • 无需分离柱
  • 兼容 EasySep™、“The Big Easy”和RoboSep™-S平台

产品组分包括

  • EasySep™ HLA嵌合全血CD3正选试剂盒(产品号#17871)          
    • EasySep™ HLA嵌合全血CD3正选抗体混合物,3 X 1mL
    • EasySep™ Dextran RapidSpheres™ 50101 磁珠,3 X 1mL
    • EasySep™ 红细胞裂解液10倍浓缩液,10 mL(产品号#20110)
  • RoboSep™ HLA嵌合全血CD3正选试剂盒(含滤芯吸头)(产品号#17871RF)
    • EasySep™ HLA嵌合全血CD3正选抗体混合物,3 X 1mL
    • EasySep™ Dextran RapidSpheres™ 50101 磁珠,3 X 1mL
    • EasySep™ 红细胞裂解液10倍浓缩液,10 mL(产品号#20110)
    • RoboSep™ 缓冲液(产品号 #20104)x 2
    • RoboSep™过滤吸头(产品号#20125)x 2
New look, same high quality and support! You may notice that your instrument or reagent packaging looks slightly different from images displayed on the website, or from previous orders. We are updating our look but rest assured, the products themselves and how you should use them have not changed. Learn more
专为您的实验方案打造的产品

总览

使用EasySep™ HLA嵌合全血CD3正选试剂盒,通过免疫磁珠正选技术从新鲜全血或白膜层样本中分离高纯度人CD3+细胞。EasySep™技术结合单克隆抗体的特异性和无需分离柱的简便磁分选系统,已在发表的研究中广泛应用超过20年。

在该EasySep™正选流程中,目的细胞通过识别CD3的抗体复合物与磁珠进行标记。抗体复合物中还含有人Fc受体抗体,可最大程度地减少非特异性结合。使用EasySep™磁分选系统分离标记细胞,只需倾倒或移液吸取非目的细胞。目的细胞保留在分离管中。细胞分选后,目的CD3+细胞即可用于流式细胞术、培养或DNA/RNA提取等下游应用。

本产品替代EasySep™人全血CD3正选试剂盒(产品号#18081)和EasySep™ HLA全血CD3正选试剂盒(产品号#18081HLA),可实现更快速的细胞分选。

深入了解免疫磁珠EasySep™技术的工作原理,或如何通过RoboSep™实现免疫磁珠细胞分选全自动化以节省时间并提升实验室通量。探索更多为您的实验流程优化的产品,包括细胞表征、冷冻保存等相关产品。

在该EasySep™正选流程中,目的细胞通过识别CD3的抗体复合物与磁珠进行标记。抗体复合物中还含有人Fc受体抗体,可最大程度地减少非特异性结合。使用EasySep™磁分选系统分离标记细胞,只需倾倒或移液吸取非目的细胞。目的细胞保留在分离管中。细胞分选后,目的CD3+细胞即可用于流式细胞术、培养或DNA/RNA提取等下游应用。

本产品替代EasySep™人全血CD3正选试剂盒(产品号#18081)和EasySep™ HLA全血CD3正选试剂盒(产品号#18081HLA),可实现更快速的细胞分选。

深入了解免疫磁珠EasySep™技术的工作原理,或如何通过RoboSep™实现免疫磁珠细胞分选全自动化以节省时间并提升实验室通量。探索更多为您的实验流程优化的产品,包括细胞表征、冷冻保存等相关产品。

在该EasySep™正选流程中,目的细胞通过识别CD3的抗体复合物与磁珠进行标记。抗体复合物中还含有人Fc受体抗体,可最大程度地减少非特异性结合。使用EasySep™磁分选系统分离标记细胞,只需倾倒或移液吸取非目的细胞。目的细胞保留在分离管中。细胞分选后,目的CD3+细胞即可用于流式细胞术、培养或DNA/RNA提取等下游应用。

本产品替代EasySep™人全血CD3正选试剂盒(产品号#18081)和EasySep™ HLA全血CD3正选试剂盒(产品号#18081HLA),可实现更快速的细胞分选。

深入了解免疫磁珠EasySep™技术的工作原理,或如何通过RoboSep™实现免疫磁珠细胞分选全自动化以节省时间并提升实验室通量。探索更多为您的实验流程优化的产品,包括细胞表征、冷冻保存等相关产品。

在该EasySep™正选流程中,目的细胞通过识别CD3的抗体复合物与磁珠进行标记。抗体复合物中还含有人Fc受体抗体,可最大程度地减少非特异性结合。使用EasySep™磁分选系统分离标记细胞,只需倾倒或移液吸取非目的细胞。目的细胞保留在分离管中。细胞分选后,目的CD3+细胞即可用于流式细胞术、培养或DNA/RNA提取等下游应用。

本产品替代EasySep™人全血CD3正选试剂盒(产品号#18081)和EasySep™ HLA全血CD3正选试剂盒(产品号#18081HLA),可实现更快速的细胞分选。

深入了解免疫磁珠EasySep™技术的工作原理,或如何通过RoboSep™实现免疫磁珠细胞分选全自动化以节省时间并提升实验室通量。探索更多为您的实验流程优化的产品,包括细胞表征、冷冻保存等相关产品。

磁体兼容性
• “The Big Easy” EasySep™ Magnet (Catalog #18001) • EasyEights™ EasySep™ Magnet (Catalog #18103) • RoboSep™-S (Catalog #21000)  
 
亚型
细胞分选试剂盒
 
细胞类型
T 细胞
 
种属

 
样本来源
Buffy Coat,Whole Blood
 
筛选方法
Positive
 
品牌
EasySep
 
研究领域
HLA,免疫
 

实验数据

Typical EasySep™ HLA Chimerism Whole Blood CD3 Positive Selection Profile

Figure 1. Typical EasySep™ HLA Chimerism Whole Blood CD3 Positive Selection Profile

Starting with human whole blood, the CD3+ cell content of the isolated fraction typically ranges from 92.4 - 99.8% (as assessed by staining the start and isolated fractions with anti-CD3 or anti-CD2 antibodies, respectively). In the above example, the purities of the start and the final isolated fractions are 18.2% and 98.1%, respectively (gated on CD45).
NOTE: Red blood cells were removed from the start sample by lysis prior to flow cytometry.

FACS Data for Anti-Human CD2 Antibody, Clone RPA-2.10, PE-Conjugated

Figure 2. FACS Data for Anti-Human CD2 Antibody, Clone RPA-2.10, PE-Conjugated

(A) Flow cytometry analysis of human peripheral blood mononuclear cells (PBMCs) labeled with Anti-Human CD2 Antibody, Clone RPA-2.10, PE (Catalog #60007PE) and anti-human CD45 APC. (B) Flow cytometry analysis of human PBMCs processed with the EasySep™ HLA CD3 Positive Selection Kit (Catalog #17871) and labeled with Anti-Human CD2 Antibody, Clone RPA-2.10, PE. Histograms show labeling of PBMCs (Start) and isolated cells (Isolated). Labeling of start cells with a mouse IgG1, kappa PE isotype control antibody is shown (open histogram).

FACS Data for Anti-Human CD5 Antibody, Clone UCHT2, PE-Conjugated

Figure 3. FACS Data for Anti-Human CD5 Antibody, Clone UCHT2, PE-Conjugated

(A) Flow cytometry analysis of human buffy coat nucleated cells labeled with Anti-Human CD5 Antibody, Clone UCHT2, PE (Catalog #60082PE) and Anti-Human CD20 Antibody, Clone 2H7, APC (Catalog #60008AZ). (B) Flow cytometry analysis of human buffy coat nucleated cells labeled with a mouse IgG1, kappa PE isotype control antibody and Anti-Human CD20 Antibody, Clone 2H7, APC. (C) Flow cytometry analysis of human buffy coat nucleated cells processed with the EasySep™ HLA CD3 Positive Selection Kit (Catalog #17871) and labeled with Anti-Human CD5 Antibody, Clone UCHT2, PE. Histograms show labeling of buffy coat nucleated cells (Start) and isolated cells (Isolated). Labeling of start cells with a mouse IgG1, kappa PE isotype control antibody is shown (solid line histogram).

产品说明书及文档

请在《产品说明书》中查找相关支持信息和使用说明,或浏览下方更多实验方案。

Document Type
Product Name
Catalog #
Lot #
Language
Catalog #
17871RF
Lot #
1000119933 or higher
Language
English
Catalog #
17871RF
Lot #
1000119933 or higher
Language
English
Catalog #
17871
Lot #
1000119933 or higher
Language
English
Catalog #
17871
Lot #
1000119933 or higher
Language
English
Document Type
Safety Data Sheet 1
Catalog #
17871RF
Lot #
All
Language
English
Document Type
Safety Data Sheet 2
Catalog #
17871RF
Lot #
All
Language
English
Document Type
Safety Data Sheet 3
Catalog #
17871RF
Lot #
All
Language
English
Document Type
Safety Data Sheet 4
Catalog #
17871RF
Lot #
All
Language
English
Document Type
Safety Data Sheet 1
Catalog #
17871
Lot #
All
Language
English
Document Type
Safety Data Sheet 2
Catalog #
17871
Lot #
All
Language
English
Document Type
Safety Data Sheet 3
Catalog #
17871
Lot #
All
Language
English

应用领域

本产品专为以下研究领域设计,适用于工作流程中的高亮阶段。探索这些工作流程,了解更多我们为各研究领域提供的其他配套产品。

相关材料与文献

技术资料 (14)

文献 (1)

Neutrophil and Granulocytic Myeloid-Derived Suppressor Cell-Mediated T Cell Suppression Significantly Contributes to Immune Dysregulation in Common Variable Immunodeficiency Disorders. M. Vlkova et al. Journal of immunology (Baltimore, Md. : 1950) 2018 NOV

Abstract

Common variable immunodeficiency disorders (CVID) represent a group of primary immunodeficiency diseases characterized by hypogammaglobulinemia and impaired specific Ab response, resulting in recurrent infections due to dysfunctional immune response. The specific mechanisms mediating immune deficiency in CVID remain to be determined. Previous studies indicated that immune dysregulation in CVID patients is associated with chronic microbial translocation, systemic immune activation, and altered homeostasis of lymphocytic and myeloid lineages. A detailed phenotypic, functional characterization of plasma markers and immune cell populations was performed in 46 CVID patients and 44 healthy donors. CVID patients displayed significantly elevated plasma levels of a marker of neutrophil activation neutrophil gelatinase-associated lipocalin. Neutrophils from CVID patients exhibited elevated surface levels of CD11b and PD-L1 and decreased levels of CD62L, CD16, and CD80, consistent with a phenotype of activated neutrophils with suppressive properties. Neutrophils from CVID patients actively suppressed T cell activation and release of IFN-$\gamma$ via the production of reactive oxygen species. Furthermore, CVID was associated with an increased frequency of low-density neutrophils (LDNs)/granulocytic myeloid-derived suppressor cells. LDN/granulocytic myeloid-derived suppressor cell frequency in CVID patients correlated with reduced T cell responsiveness. Exogenous stimulation of whole blood with bacterial LPS emulated some but not all of the phenotypic changes observed on neutrophils from CVID patients and induced neutrophil population with LDN phenotype. The presented data demonstrate that neutrophils in the blood of CVID patients acquire an activated phenotype and exert potent T cell suppressive activity. Specific targeting of myeloid cell-derived suppressor activity represents a novel potential therapeutic strategy for CVID.

更多信息

更多信息
种属 Human
Magnet Compatibility • “The Big Easy” EasySep™ Magnet (Catalog #18001) • EasyEights™ EasySep™ Magnet (Catalog #18103) • RoboSep™-S (Catalog #21000)
样本来源 Buffy Coat, Whole Blood
Selection Method Positive
标记抗体
质量保证:

产品仅供研究使用,不用于针对人或动物的诊断或治疗。 欲获悉更多关于STEMCELL的质控信息,请访问 STEMCELL.CN/COMPLIANCE.
Copyright © 2025 by STEMCELL Technologies. All rights reserved.